Cargando…
Superiority of Direct Oral Anticoagulants over Vitamin K Antagonists in Oncological Patients with Atrial Fibrillation: Analysis of Efficacy and Safety Outcomes
Background and aim. Cancer and atrial fibrillation (AF) may be associated, and anticoagulation, either with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), is necessary to prevent thromboembolic events by reducing the risk of bleeding. The log incidence rate ratio (IRR) and 95% c...
Autores principales: | Parrini, Iris, Lucà, Fabiana, Rao, Carmelo Massimiliano, Parise, Gianmarco, Micali, Linda Renata, Musumeci, Giuseppe, La Meir, Mark, Colivicchi, Furio, Gulizia, Michele Massimo, Gelsomino, Sandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572823/ https://www.ncbi.nlm.nih.gov/pubmed/36233581 http://dx.doi.org/10.3390/jcm11195712 |
Ejemplares similares
-
Breast Cancer and Atrial Fibrillation
por: Mauro, Emanuela, et al.
Publicado: (2022) -
Obstructive Sleep Apnea and Atrial Fibrillation
por: Moula, Amalia Ioanna, et al.
Publicado: (2022) -
Quantification of Death Risk in Relation to Sex, Pre-Existing Cardiovascular Diseases and Risk Factors in COVID-19 Patients: Let’s Take Stock and See Where We Are
por: Moula, Amalia Ioanna, et al.
Publicado: (2020) -
Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account
por: Lucà, Fabiana, et al.
Publicado: (2021) -
Management of Acute Coronary Syndrome in Cancer Patients: It’s High Time We Dealt with It
por: Lucà, Fabiana, et al.
Publicado: (2022)